These are the FACTS about America’s problem with opioids…
Scary and sad – right?
Enter AcelRx Pharmaceuticals and the FDA. AcelRx Pharmaceuticals has created a new opioid called Dsuvia. And that new opioid has just been approved by the FDA.
One might ask – given all of the abuse of prescription opioids – why would the FDA allow another into the U.S. market?
Well – how about if we told you Dsuvia is ten times more potent than fentanyl and 1,000 times more potent than morphine?
Does the drug have benefits that outweigh the risks of approval and distribution?
According to Raeford Brown, chair of the FDA’s Anesthetic and Analgesic Drug Products Advisory Committee – no. None.
He also said, I “predict that we will encounter diversion, abuse, and death within the early months of its availability on the market.”
Public Citizen’s Health Research Group went further to describe Dsuvia as an “opioid with no unique benefit but unique harms.”
So why on earth would the FDA allow the introduction in the U.S. of yet another opioid – one more dangerous than all the others?
Some suggest cynically that the FDA is a wholly-owned subsidiary of the drug companies.
If the drug companies do in fact, have undue influence over regulatory matters at FDA – that my friends is a serious problem.
One thing is clear - the new Congress must seek answers on this matter immediately upon taking office.
If you are struggling with an addiction to drugs and/or alcohol and need help in Connecticut, New Hampshire or southern Maine, the recovery teams at Aware Recovery Care are here to help. Our unique model of care is giving clients a 6X better chance of recovery when compared to traditional inpatient rehab care. To learn more or to talk to one of our Recovery Specialists, visit www.awarerecoverycare.com.